서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 33 of 33

Issue DateTitle / Author(s) / CitationFileAltmetrics
2003-08
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial
DOI
2004-07
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2004-08
First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer

Park, SH; Bang, SM; Cho, EK; Baek, JH; Oh, JH; Im, SA; Park, YS; Shin, DB; Lee, JH

Oncology, Vol.66 No.5, pp.353-357

DOI
2005-01
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
DOI
2005-08
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer

Cho, EK; Lee, WK; Im, SA; Lee, SN; Park, SH; Bang, SM; Park, DK; Park, YH; Shin, DB; Lee, JH

Oncology, Vol.68 No.4-6, pp.333-340

DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2007-09
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view file
2007-11
Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer
DOI
2008-03
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
DOI
2009-04
A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor
DOI
2009-09
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
DOI
2009-09
Results of breast-conserving therapy for multifocal or multicentric breast cancers

Chie, Eui Kyu; Kim, Kyubo; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

Asia-Pacific Journal of Clinical Oncology, Vol.5 No.3, pp.200-205

DOI
2009-12
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
view fileDOI
2010-01
The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy
DOI
2010-06
The prognostic significance of ERCC1, BRCA1, XRCC1, and beta 111-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection
DOI
2011-02
Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study
DOI
2011-04
Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study
DOI
2011-05
Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer
DOI
2012-01
Conflict of Interest in the Assessment of Thromboprophylaxis After Total Joint Arthroplasty A Systematic Review

Lee, Young-Kyun; Chung, Chin Youb; Koo, Kyung-Hoi; Lee, Kyoung Min; Ji, Hyung-Min; Park, Moon Seok

Journal of Bone and Joint Surgery - Series A, Vol.94A No.1, pp.27-33

DOI
2012-04
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01
DOI
2012-12
Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer
view fileDOI
2013-08
Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
DOI
2015-09
Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro
DOI
2015-10
Educational intervention as an effective step for reducing blood culture contamination: a prospective cohort study

Park, W. B.; Myung, S. J.; Oh, M. -D.; Lee, J.; Kim, N. -J.; Kim, E. -C.; Park, J. S.

Journal of Hospital Infection, Vol.91 No.2, pp.111-116

DOI
2016-04
Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer patients in stage II in the 7th TNM but stage I in the 6th TNM system?
DOI
2016-05
A comparative study of daily 3-Gy hypofractionated and 1.8-Gy conventional breast irradiation in early-stage breast cancer
DOI
2016-07
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
view fileDOI
2016-12
Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features
DOI
2016-12
Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion
DOI
2017-06
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
DOI
2018-04
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results
DOI
2019-05
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC
DOI
2020-03
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
DOI
1